Sculati Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.18M Buy
2,366
+40
+2% +$40.6K 0.8% 39
2025
Q4
$2.5M Sell
2,326
-21
-0.9% -$20.1K 0.88% 36
2025
Q3
$1.79M Buy
2,347
+216
+10% +$161K 0.63% 47
2025
Q2
$1.66M Buy
2,131
+300
+16% +$233K 0.62% 51
2025
Q1
$1.51M Buy
1,831
+289
+19% +$240K 0.61% 47
2024
Q4
$1.19M Buy
1,542
+140
+10% +$116K 0.47% 52
2024
Q3
$1.24M Buy
1,402
+586
+72% +$527K 0.5% 56
2024
Q2
$739K Hold
816
0.32% 66
2024
Q1
$635K Buy
816
+16
+2% +$11.4K 0.27% 70
2023
Q4
$466K Hold
800
0.22% 75
2023
Q3
$430K Hold
800
0.22% 76
2023
Q2
$375K Hold
800
0.19% 80
2023
Q1
$275K Sell
800
-30
-4% -$10.1K 0.15% 90
2022
Q4
$304K Sell
830
-70
-8% -$24.8K 0.17% 83
2022
Q3
$291K Hold
900
0.17% 94
2022
Q2
$292K Hold
900
0.17% 94
2022
Q1
$258K Hold
900
0.13% 104
2021
Q4
$249K Hold
900
0.12% 101
2021
Q3
$208K Hold
900
0.11% 107
2021
Q2
$207K Buy
+900
New +$181K 0.11% 108

Other funds holding LLY

Sculati Wealth Management's LLY Position: Q1 2026 in Review

Sculati Wealth Management increased its Eli Lilly (LLY) stake by 1.7% in Q1 2026, buying an estimated $40.6K and bringing the position to 2,366 shares worth $2.18M. The position accounts for 0.8% of the portfolio, ranked #39.

Sculati Wealth Management first reported a position in LLY in Q2 2021 and has held it in 20 quarters since. The position peaked at $2.5M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Sculati Wealth Management held 2,366 shares of Eli Lilly worth $2.18M as of Q1 2026.
  • Sculati Wealth Management bought 40 Eli Lilly shares in Q1 2026, an estimated $40.6K.
  • Eli Lilly made up 0.8% of Sculati Wealth Management's portfolio in Q1 2026, its #39 holding.
  • Sculati Wealth Management first reported a position in Eli Lilly in Q2 2021 and has held it in 20 quarters since.
  • Sculati Wealth Management's Eli Lilly position peaked at $2.5M in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Sculati Wealth Management's 13F filing for Q1 2026, filed 9 Apr 2026.